Generic Pharmaceutical Assoc to Testify Before House Committee on Generic Utilization, USA

Main Category: Pharma Industry / Biotech Industry
Article Date: 18 May 2005 - 10:00 PDT

email to a friend   printer friendly   opinions  

Kathleen Jaeger, President and CEO of the Generic Pharmaceutical Association, will testify on Wednesday, May 18 before the House Energy and Commerce Subcommittee on Health on "opportunities to achieve substantial savings for patients through greater generic utilization."

In her testimony, Jaeger will discuss a variety of measures that states have enacted to promote generic usage to reduce Medicaid costs, as well as offer suggestions for Congress on how to capitalize on the substantial savings generics provide to the health care system as it debates how to handle increasing health care costs.

The hearing will be held at 1 p.m. in room 2322 of the Rayburn House Office Building. CLICK HERE for additional information.

GPhA represents the manufacturers and distributors of finished generic pharmaceuticals, manufacturers and distributors of bulk active pharmaceutical chemicals, and suppliers of other goods and services to the generic drug industry. Generics represent 53% of the total prescriptions dispensed in the United States, but only 12% of all dollars spent on prescription drugs. For further information, please contact GPhA at 703-647-2480, or visit our web site at http://www.gphaonline.org.

Contact: Andrea Hofelich, GPhA
703-647-2495

• Additional
• References
• Citations